Henri-Georges Clouzot enjoyed a 40-year career in films in his native France, and saw his reputation rise and fall amid the changing tastes of audiences and critics, at home and internationally. Acclaimed in particular for his thrillers, Clouzot was one of the genuine rivals to Alfred Hitchcock and, at his peak, seemed to anticipate the moves of the better-known English director. Born in 1907 in Niort, Clouzot intended upon a career in the French navy but was barred from that opportunity by poor eyesight and chronic ill health. He studied political science with the intention of joining the diplomatic service and he served on the staff of a Rightist political figure after graduation from college, but in the late '20s, Clouzot moved into writing, first as a journalist and, starting in the early '30s, as a screenwriter and playwright. He co-authored numerous scripts between 1931 and 1933, in addition to making the short thriller La Terreur des Batignolles and serving as an assistant to several directors, including Anatole Litvak, E.A. Dupont, and Karl Hartl, on various projects.
Clouzot's initial start in films was interrupted in the mid-'30s when his declining health forced him to take four years off. He returned to work in 1938 as a screenwriter and made his debut as a feature-film director four years later, with L'Assassin Habite au 21 (aka The Murderer Lives at Number 21) (1942). Clouzot's initial work as a filmmaker was complicated by the fact that it took place during the Nazi occupation of France. His second movie, Le Corbeau (1943), was singled out for attack over its harsh look at provincial France and the fact that it was released by a company with close ties to the Nazis -- the movie was suppressed for a time after WWII and Clouzot was barred from making movies until 1947. He reestablished his reputation and popularity in France during the late '40s with movies such as Quai des Orfèvres (1947), which got an American release (as Jenny Lamour) and Manon (1949), although his output was restricted somewhat by continued health problems.